CURRICULUM VITAE NAME & SURNAME: Mehmet Kanbay BIRTH DATE: March 2 th 1974 BIRTH PLACE: Zile-Tokat NATIONALITY: Turkish MARITAL STATUS: Married FOREIGN LANGUAGE: English (advanced in writing and speaking) WORK ADRESS: Nefroloji Bilim Dalı İstanbul Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi Doktor erkin caddesi. Kadıköy / İstanbul Present Title : Associate Professor MD, Department of Medicine, Division of Nephrology, Medeniyet University School of Medicine, Goztepe Training and Research Hospital, Goztepe, Istanbul Office Telephone : +90 216 280 33 33 dect 9142 Mobile Phone : +90 505 2668866 E-mail : drkanbay@yahoo.com Home address: Zumrutevler Mahallesi, Kiptaş-Seyrantepe Sitesi, A1 blok, No:51 Maltepe, Istanbul, Turkey 1
EDUCATION TRAINING EMPLOYMENT 1982-1987 Ibni Kemal Primary School, Tokat 1987-1990 Tokat Anadolu High School, Tokat 1990-1993 Private Science High School, İzmir 1993-2000 Istanbul University, Cerrahpasa School of Medicine (in English), Istanbul 2000-2005 Residency, Department of Internal Medicine, Baskent University School of Medicine, Ankara 2005-2007 Residency, Section of Nephrology, Fatih University School of Medicine, Ankara 2007-2008 Clinical Fellowship (International Society of Nephrology (ISN)), Yale University School of Medicine in Section of Nephrology, Connecticut, USA 2009-2010 Turkish Mandatory Military Service, Gulhane Military Medical School, Department of Medicine, Division of Nephrology, Ankara, Turkey 2010-2012 Department of Medicine, Division of Nephrology Kayseri Training and Research Hospital 2012- MD, Division of of Nephrology, Department of Medicine Medeniyet University School of Medicine 2
RESEARCH INTEREST 1. Vascular calcification in chronic kidney disease 2. Cardiovascular Disease in chronic kidney disease 3. Uric acid in chronic kidney disease and cardiovascular disease 4. Anemia in chronic kidney disease 5. Hypertension Scientific Activities: Board Member of EUROCA-M Working group. An active working group of ERA- EDTA (European Renal Association). http://www.era-edta.org/eureca-m/eureca-m_aims.htm STATISTIC PROGRAM 1. Advanced user of SPSS program (I have also course certificate from Yale University School of Medicine) 2. I can give lectures about how to use SPSS in medicine MEMBERSHIPS: 1. International Society of Nephrology (ISN) 2. American Society of Nephrology 3. European Renal Association- European Dialysis and Transplantation Association 4. European Cardio-Renal Medicine Working group board member (EUROCA-M) 5. ERA-EDTA Chronic Kidney Disease-Mineral Bome Disorder Working Group Member 6. Turkish Society of Nephrology 3
INVITED JOURNAL EDITOR: 1. Editor of Private issue with Richard Johnson Seminars in Nephrology, Uric acid issue, 2011 Sep;31(5):391-3. JOURNAL EDITORIAL BOARD MEMBER: 1. International journal of urology and nephrology 2. Nephrology reviews 3. Journal of Geriatric Cardiology 4. World Journal of Nephrology REVIEWER for SCI SCIE JOURNALS: 1. Clinical journal of American society of nephrology 2. Nephrology dialysis and transplantation 3. American Journal of Hypertension 4. Clinical and Experimental Hypertension 5. Renal Failure 6. Nephron Clinical Practice 7. Blood Purification 8. Kidney Blood Pressure and Research MODERATORSHIP and REVIEWERSHIP in INTERNATIONAL MEETINGS: 1. Chairman of Risk factors for Cardiovascular Disease and Chronic Kidney Disease symposium. European Renal Association-European Dialysis and Transplantation (ERA-EDTA), Germany, Munich, June 23-26, 2011. 2. Member of Paper selection Committee of Ulusal Nefroloji Kongresi 2011 and 2012 3. Member of Paper selection Committee of Güncel Böbrek Hastalıkları ve Hipertansiyon Toplantısı 2011 and 2012. Invited speakers in many international and national congresses. 4
PUBLICATIONS: H-index: 22 TOTAL NUMBER OF CITATIONS: 1605 INTERNATIONAL BOOK CHAPTERS: 1. Uric acid and Kidney Disease Chapter: Diseases of the Kidney and Urinary Tract, 9.th Edition, 2013 (IN PRESS) 2. Urate Nephropathy Chapter: Oxford Textbook of Nephrology, 4.th Edition, 2013 (In Press) 5
PEER-REVIEWED PUBLICATIONS INDEXED IN SCI SCIE JOURNALS 1. Kanbay M, Turak O, Johnson RJ. REPLY TO: Serum uric acid still carries controversies about its role in endothelial dysfunction. J Clin Hypertens (Greenwich). 2013 Apr;15(4):297. 2. Johnson RJ, Sánchez-Lozada LG, Mazzali M, Feig DI, Kanbay M, Sautin YY. What are the key arguments against uric Acid as a true risk factor for hypertension? Hypertension. 2013 May;61(5):948-51. 3. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013 Jun;99(11):759-66. 4. Turak O, Ozcan F, Tok D, Işleyen A, Sökmen E, Taşoğlu I, Aydoğdu S, Sen N,McFann K, Johnson RJ, Kanbay M. Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J Clin Hypertens (Greenwich). 2013 Jan;15(1):7-13. 5. Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M, Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol. 2012 Dec 15. [Epub ahead of print] 6. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal- Jimenez CA, Ishimoto T, Li N, Marek G, Duranay M, Schreiner G, Rodriguez-Iturbe B,Nakagawa T, Kang DH, Sautin YY, Johnson RJ. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012 Nov 23;287(48):40732-44. 7. Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Serum Uric Acid Independently Predicts Cardiovascular Events in Advanced Nephropathy. Am J Nephrol 2012;36:324-331. 8. Turkmen K, Tonbul HZ, Erdur FM, Guney I, Kayikcioglu H, Altintepe L, Ozbek O,Yilmaz MI, Gaipov A, Turk S, Covic A, Kanbay M. Peri-aortic fat tissue and malnutrition-inflammation atherosclerosis/calcification syndrome in end-stage renal disease patients. Int Urol Nephrol. 2012 Sep 23. [Epub ahead of print] 6
9. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K,Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Relationship between Serum Magnesium Levels and Cardiovascular Events in Chronic Kidney Disease Patients. Am J Nephrol. 2012 Aug 30;36(3):228-237. 10. Solak Y, Biyik Z, Atalay H, Gaipov A, Guney F, Turk S, Covic A, Goldsmith D, Kanbay M. Pregabalin versus Gabapentin in the Treatment of Neuropathic Pruritus in Maintenance Hemodialysis Patients: a Prospective Crossover Study. Nephrology (Carlton). 2012 Aug 22. doi: 10.1111/j.1440-1797.2012.01655. 11. Ozkok A, Elcioglu OC, Cukadar T, Bakan A, Sasak G, Atilgan KG, Alisir S, Kanbay M, Covic A, Odabas AR. Low serum pancreatic enzyme levels predict mortality and are associated with malnutrition-inflammation-atherosclerosis syndrome in patients with chronic kidney disease. Int Urol Nephrol. 2012 Aug 2.[Epub ahead of print] 12. Solak Y, Gul EE, Kayrak M, Atalay H, Abdulhalikov T, Turk S, Covic A, Kanbay M. Electrocardiographic P-wave characteristics in patients with end-stage renal disease: P-index and interatrial block. Int Urol Nephrol. 2012 May 12. 13. Akin F, Ayça B, Köse N, Duran M, Sari M, Uysal OK, Karakukcu C, Arinc H, Covic A, Goldsmith D, Okçün B, Kanbay M. Serum vitamin D levels are independently associated with severity of coronary artery disease. J Investig Med. 2012 Aug;60(6):869-73. 14. Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU, Gok M, Vural A, Covic A. Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor? Int Urol Nephrol. 2012 Mar 23. [Epub ahead of print] 15. Cakar M, Kanbay M, Sarlak H, Akhan M, Gok M, Unal HU, Demirbas S, Yilmaz MI.Findings of biopsy-proven chronicity and end-stage renal failure associated with oral sodium phosphate solution. Ren Fail. 2012;34(4):499-501. 16. Akcay AB, Ozlu MF, Sen N, Cay S, Ozturk OH, Yalcn F, Bilen P, Kanat S, Karakas MF, Isleyen A, Demir AD, Sogut S, Covic A, Kanbay M. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction. J Investig Med. 2012 Feb;60(2):508-13. 17. Afsar B, Elsurer R, Covic A, Kanbay M. Vascular access type, health-related quality of life, and depression in hemodialysis patients: a preliminary report. J Vasc Access. 2012 Apr-Jun;13(2):215-20. 18. Kanbay M, Wolf M, Selcoki Y, Solak Y, Ikizek M, Uysal S, Segall L, Armutcu F, Eryonucu B, Duranay M, Goldsmith D, Covic A. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. Int Urol Nephrol. 2012 Aug;44(4):1169-75. 7
19. Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz G, Furst DE, Ben-Chetrit E. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S77-86. Epub 2011 Sep 27. Review. 20. Johnson RJ, Kanbay M, Sánchez-Lozada LG. The rediscovery of uric acid in cardiorenal disease: introduction. Semin Nephrol. 2011 Sep;31(5):391-3. 21. Afsar B, Elsurer R, Kanbay M. The relationship between breakfast, lunch and dinner eating pattern and hemodialysis sessions, quality of life, depression and appetite in hemodialysis patients. Int Urol Nephrol. 2012 Oct;44(5):1507-14. 22. Johnson RJ, Kanbay M, Kang DH, Sánchez-Lozada LG, Feig D. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension. 2011 Oct;58(4):548-9. 23. Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M. Renal anemia of inflammation: the name is self-explanatory. Blood Purif. 2011;32(3):220-5. 24. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, Duranay M, Covic A, Johnson RJ. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011 Aug;6(8):1887-94. 25. Kanbay M, Turkmen K, Ecder T, Covic A. Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol. 2012 Feb;44(1):173-82. 26. Sen N, Ozlu MF, Akgul EO, Kanat S, Cayci T, Turak O, Yaman H, Sokmen E, Ozcan F, Maden O, Demir AD, Covic A, Kanbay M. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion. Atherosclerosis. 2011 Nov;219(1):304-10. 27. Kanbay M, Solak Y, Covic A, Goldsmith D. Sudden cardiac death in patients with chronic kidney disease: prevention is the sine qua non. Kidney Blood Pres Res. 2011;34(4):269-76. 28. Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol. 2011;34(1):49-54. 29. Kanbay M, Afsar B, Covic A. Uric acid as a cardiometabolic risk factor: to be or not to be. Contrib Nephrol. 2011;171:62-7. 30. Karadag R, Keskin UC, Koktener A, Selcoki Y, Hepsen IF, Kanbay M. Ocular pulse amplitude and retrobulbar blood flow change in dipper and non-dipper individuals. Eye (Lond). 2011 Jun;25(6):762-6. 8
31. Basar N, Sen N, Ozcan F, Erden G, Kanat S, Sokmen E, Isleyen A, Yuzgecer H, Ozlu MF, Yildirimkaya M, Maden O, Covic A, Johnson RJ, Kanbay M. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Investig Med. 2011 Aug;59(6):931-7. 32. Kanbay M, Ikizek M, Solak Y, Selcoki Y, Uysal S, Armutcu F, Eryonucu B, Covic A, Johnson RJ. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011;33(4):325-31. 33. Kanbay M, Yilmaz MI, Sonmez A, Turgut F, Saglam M, Cakir E, Yenicesu M, Covic A, Jalal D, Johnson RJ. Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol. 2011;33(4):298-304. 34. Basar N, Sen N, Kanat S, Ozlu MF, Ozcan F, Cay S, Erden G, Cagli KE, Yildirimkaya M, Maden O, Covic A, Kanbay M. Lower fetuin-a predicts angiographic impaired reperfusion and mortality in ST-elevation myocardial infarction. J Investig Med. 2011 Jun;59(5):816-22. 35. Kanbay M, Chen Y, Solak Y, Sanders PW. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens. 2011 Jan;20(1):37-43. 36. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A. Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif. 2010;30(4):288-95. 37. Duranay M, Segall L, Sen N, Yilmaz FM, Cetin M, Isleyen A, Kanbay M, Covic A. Bone morphogenic protein-7 serum level decreases significantly in patients with contrast-induced nephropathy. Int Urol Nephrol. 2011 Sep;43(3):807-12. 38. Kanbay M, Sánchez-Lozada LG, Franco M, Madero M, Solak Y, Rodriguez-Iturbe B, Covic A, Johnson RJ. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant. 2011 Feb;26(2):430-7. 39. Kanbay M, Afsar B, Goldsmith D, Covic A. Sudden death in hemodialysis: an update. Blood Purif. 2010;30(2):135-45. 40. Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol. 2010 Oct;5(10):1780-6. 41. Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A. A forgotten but important risk factor for severe hyponatremia: myxedema coma. Clinics (Sao Paulo). 2010 Apr;65(4):447-8. 9
42. Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ. Vascular calcification in chronic kidney disease. Clin Sci (Lond). 2010 Apr 28;119(3):111-21. 43. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, Johnson RJ. Uric acid and hypertension: cause or effect? Curr Rheumatol Rep. 2010 Apr;12(2):108-17. 44. Bavbek N, Akay H, Uz B, Uz E, Turgut F, Kanbay M, Senes M, Akcay A, Duranay M. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients. Ren Fail. 2010 Jan;32(2):157-61. 45. Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif. 2010;29(3):280-92. 46. Türkay C, Aydoğan T, Karanfil A, Uyar ME, Selçoki Y, Kanbay M. T-wave depletion and bradycardia possibly secondary to acute pancreatitis: review of the literature. Turk J Gastroenterol. 2009 Dec;20(4):295-7. 47. Duranay M, Kanbay M, Akay H, Unverdi S, Sürer H, Altay M, Kirbaş I, Covic A,Zoccali C. Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: a pilot study. Nephron Clin Pract. 2010;114(3):c213-7. 48. Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A. Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol. 2010 Sep;42(3):741-52. 49. Kanbay M, Kasapoglu B, Perazella MA. Acute tubular necrosis and pre-renal acute kidney injury: utility of urine microscopy in their evaluation- a systematic review. Int Urol Nephrol. 2010 Jun;42(2):425-33. 50. Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purif. 2010;29(1):1-12. 51. Kanbay M, Turgut F, Covic A, Goldsmith D. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence. J Nephrol. 2009 Sep-Oct;22(5):598-609. 52. Turgut F, Kasapoğlu B, Kanbay M. Uric acid, cardiovascular mortality, and longterm outcomes in CKD. Am J Kidney Dis. 2009 Sep;54(3):582; author reply 53. Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol. 2009;41(3):617-27. 54. Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009 Jun;22(3):309-15. 55. Kanbay M, Goldsmith D, Akcay A, Covic A. Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif. 2009;27(2):220-30. 10
56. Kanbay M, Kasapoglu B, Akcay A. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy. JAMA. 2009 Jan 28;301(4):378;author reply 57. Bavbek N, Isik B, Kargili A, Uz E, Uz B, Kanbay M, Turgut F, Karakurt F, Akcay A. Association of obesity with inflammation in occult chronic kidney disease. J Nephrol. 2008 Sep-Oct;21(5):761-7. 58. Kurtaran H, Uyar ME, Kasapoglu B, Turkay C, Yilmaz T, Akcay A, Kanbay M. Role of Helicobacter pylori in pathogenesis of upper respiratory system diseases. J Natl Med Assoc. 2008 Oct;100(10):1224-30. 59. Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant. 2008 Nov;8(11):2378-90. Review. Erratum in: Am J Transplant. 2009 Apr;9(4):865.Kambay, M [corrected to Kanbay, M]. 60. Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. Causes and mechanisms of nondipping hypertension. Clin Exp Hypertens. 2008 Oct;30(7):585-97. 61. Kanbay M, Kasapoglu B, Turgut F, Akcay A. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008 Oct;74(7):967-8; author reply 968. 62. Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol. 2008 Nov;3(6):1615-9. 63. Selcuk H, Korkmaz M, Kanbay M, Tore E, Sumer H, Unal H, Yeloglu O, Gur G, Bilezikci B, Demirhan B, Yilmaz U, Boyacioglu S. Total colonic polyp diameter: a marker for the risk of malignancy? Hepatogastroenterology. 2008 May- Jun;55(84):936-9. 64. Karadag R, Yagci R, Aydin B, Kanbay M, Erdurmus M, Keskin UC, Akcay A, Durmus M. Effects of erytropoietin treatment and hemodialysis on the serum endothelin level and intraocular pressure of hemodialysis patients. Int Ophthalmol. 2009 Oct;29(5):385-8. 65. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol. 2008;40(4):1075-82. 66. Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and metaanalysis. Am J Kidney Dis. 2008 Aug;52(2):262-71. 11
67. Uz E, Bayrak O, Uz E, Kaya A, Bayrak R, Uz B, Turgut FH, Bavbek N, Kanbay M, Akcay A. Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: an experimental model. Am J Nephrol. 2008;28(3):517-22. 68. Selcoki Y, Gorpelioglu C, Turgut F, Sarifakioglu E, Ozkara A, Tekin O, Kanbay M, Akcay A. Isotretinoin: is there any arrhythmic effect? Int J Dermatol. 2008 Feb;47(2):195-7. 69. Altay M, Turgut F, Akay H, Kanbay M, Babali A, Akcay A, Duranay M, Yigitoglu R, Covic A. Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. Int Urol Nephrol. 2008;40(1):211-7. 70. Ozkara A, Turgut F, Selcoki Y, Karanfil A, Metin MR, Kanbay M, Tekin O, Akcay A. Probrain natriuretic peptide for assessment of efficacy in heart failure treatment. Adv Ther. 2007 Nov-Dec;24(6):1233-9. 71. Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A, Yigitoglu R, Covic A. Relation between serum thyroid hormone and 'nondipper' circadian blood pressure variability. Kidney Blood Press Res. 2007;30(6):416-20. 72. Uz E, Bavbek N, Turgut FH, Kanbay M, Kaya A, Akcay A. Cefuroxime-induced lupus. J Natl Med Assoc. 2007 Sep;99(9):1066-7. 73. Turgut F, Bayrak O, Kanbay M, Ozkara A, Uz E, Bavbek N, Kargili A, Akcay A. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia. Scand J Urol Nephrol. 2008;42(1):47-52. 74. Türkay C, Yönem O, Arici S, Koyuncu A, Kanbay M. Effect of angiotensinconverting enzyme inhibition on experimental hepatic fibrogenesis. Dig Dis Sci. 2008 Mar;53(3):789-93. 75. Kanbay M, Isik B, Akcay A, Ozkara A, Karakurt F, Turgut F, Alkan R, Uz E,Bavbek N, Yigitoglu R, Covic A. Relation between serum calcium, phosphate,parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function. Am J Nephrol. 2007;27(5):516-21. 76. Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N, Uz E, Akcay A, Yigitoglu R, Covic A. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39(4):1227-33. 77. Turgut F, Kanbay M, Kaya A, Uz B, Akcay A. Bilateral renal artery embolization in a case with severe proteinuria secondary to amyloidosis in a hemodialysis patient. Amyloid. 2007 Jun;14(2):157-8. 12
78. Kanbay M, Akcay A, Delibasi T, Uz B, Kaya A, Koca C, Turgut F, Bavbek N, Uz E, Duranay M, Yigitoglu R. Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure. Adv Ther. 2007 Mar-Apr;24(2):346-52. 79. Yanik B, Bavbek N, Yanik T, Inegöl I, Kanbay M, Turgut FH, Uz E, Akçay A. The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women. Ren Fail. 2007;29(4):471-6. 80. Kanbay M, Bavbek N, Delibasi T, Koca C, Kaya A, Altay M, Akcay A, Duranay M, Yigitoglu R. Effect of peritoneal dialysis solution type on serum lipid levels in endstage renal disease. Ren Fail. 2007;29(3):309-13. 81. Turgut F, Kanbay M, Isik B, Akcay A. Risk factors affecting the incidence of chronic kidney disease. Kidney Int. 2007 May;71(10):1076; authoe reply 1076. 82. Aytac S, Türkay C, Kanbay M. Helicobacter pylori stool antigen assay in hyperemesis gravidarum: a risk factor for hyperemesis gravidarum or not? Dig Dis Sci. 2007 Oct;52(10):2840-3. 83. Duranay M, Kanbay M, Turgut F, Altay M, Akcay A. Comparison of incidence of peritonitis between peritoneal dialysis solution types. Nephron Clin Pract. 2007;106(1):c57-60. 84. Selcuk H, Uruc I, Temel MA, Ocal S, Huddam B, Korkmaz M, Unal H, Kanbay M, Savas N, Gur G, Yilmaz U, Haberal M. Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease. Dig Dis Sci. 2007 Nov;52(11):3217-23. 85. Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: Helicobacter pylori infection. Med Hypotheses. 2007;69(3):709-10. 86. Kanbay M, Kasapoglu B, Isik B, Turgut F, Uz E, Bavbek N, Akcay A. H. pylori: a major risk factor for 'non-dipper' circadian variability profile in blood pressure? Med Hypotheses. 2007;69(2):463-4. 87. Turgut F, Kanbay M, Uz B, Carlioglu A, Selcoki Y, Karanfil A, Alici O, Akcay A. A forgotten but important risk factor for infective endocarditis in patients with prosthetic valve: pedicure. Scand J Infect Dis. 2007;39(3):274-6. 88. Kanbay M, Alkis M, Turgut F, Uz E, Bavbek N, Akcay A. Hyponatremia due to an additive effect of carbamazepine and clarithromycin. South Med J. 2007 Feb;100(2):222. 89. Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A. Helicobacter pylori: a major risk factor for endothelial dysfunction? Med Hypotheses. 2007;69(1):227-8. 90. Kanbay M, Selcuk H, Yilmaz U, Boyacioglu S. Recurrent acute pancreatitis probably secondary to lisinopril. South Med J. 2006 Dec;99(12):1388-9. 13
91. Selcuk H, Kanbay M, Korkmaz M, Gulsener P, Gur G, Yilmaz U, Boyacioglu S. Route of nutrition has no effect on the development of infectious complications. J Natl Med Assoc. 2006 Dec;98(12):1963-6. 92. Altay M, Kanbay M, Kurultak I, Altay FA, Aydogan T, Akcay A, Duranay M. A case of bilateral psoas abscesses and lumbar osteomyelitis due to recurrent salmonella infection. J Natl Med Assoc. 2006 Nov;98(11):1855-6. 93. Kaya A, Kanbay M, Bayrak O, Eken G, Memis L, Akcay A, Duranay M. Primary renal lymphoma associated with hepatitis C virus infection. Leuk Lymphoma. 2006 Sep;47(9):1976-8. 94. Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M,Yigitoglu R. Effect of dialysis type on serum lipids, polipoproteins, and lipoproteins. Ren Fail. 2006;28(7):567-71. 95. Usta B, Gozdemir M, Turgut F, Sert H, Kanbay M, Demircioglu RI, Akcay A. Does hypocalcemia trigger pulmonary embolism? Med Hypotheses. 2007;68(2):464-5. 96. Sahin M, Tutuncu NB, Kanbay M, Guvener ND. Surgery for hyperthyroidism in Down syndrome: case report. Mt Sinai J Med. 2006 Sep;73(5):784-6. 97. Kanbay M, Gur G, Akcay A, Selcuk H, Yilmaz U, Arslan H, Boyacioglu S, Ozdemir FN. Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients? Dig Dis Sci. 2006 Nov;51(11):1962-6. 98. Aydogan T, Kanbay M, Alici O, Kosar A. Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets. 2006 Aug;17(5):328-31. 99. Kanbay M, Selcuk H, Gur G, Yilmaz U, Boyacioglu S. Involvement of the esophagus in a patient with pemphigus vulgaris who was on immunosuppressive therapy. J Natl Med Assoc. 2006 Aug;98(8):1369-70. 100. Guler ZM, Kanbay A, Kanbay M, Ciftci B, Erdogan Y. Tuberculous epididymitis presenting with Addison's disease: a rare case. J Natl Med Assoc. 2006 Jul;98(7):1175-6. 101. Kanbay M, Altundag K, Gur G, Boyacioglu S. Non-Hodgkin's lymphoma presenting with granulomatous hepatitis and hemophagocytosis. Leuk Lymphoma. 2006 Apr;47(4):767-9. 102. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, Ozdemir N, Yilmaz U, Boyacioglu S. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig Dis Sci. 2006 Aug;51(8):1420-5. 103. Kanbay M, Selcuk H, Yilmaz U. Dysphagia caused by cervical osteophytes: a rare case. J Am Geriatr Soc. 2006 Jul;54(7):1147-8. 14
104. Kanbay M, Aydogan T, Bozalan R, Isik A, Uz B, Kaya A, Akcay A. A Rare but serious side effect of Levofloxacin: hypoglycemia in a geriatric patient. Diabetes Care. 2006 Jul;29(7):1716-7. 105. Kaya A, Kanbay M, Bayrak O, Kurtaran H, Ark N, Catal F, Akcay A. Concomitant nephrotic syndrome with antinuclear antibody seropositivity and Hashimoto thyroiditis in a patient with mycosis fungoides. South Med J. 2006 Jun;99(6):631. 106. Kanbay M, Kaya A, Bozalan R, Aydogan T, Uz B, Isik A, Akcay A. Gabapentin induced edema in a geriatric patient. Clin Neuropharmacol. 2006 May-Jun;29(3):186. 107. Kanbay M, Kanbay A, Boyacioglu S. Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir Med. 2007 Feb;101(2):203-9. 108. Kanbay M, Yildirir A, Ulus T, Bilgi M, Kucuk A, Muderrisoglu H. Rhesus positivity and low high-density lipoprotein cholesterol: a new link? Asian Cardiovasc Thorac Ann. 2006 Apr;14(2):119-22. 109. Kanbay M, Selcuk H, Gur G, Dagli N, Karakus S, Yilmaz U. Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes. Am J Hematol. 2006 Apr;81(4):304-5. 110. Kanbay M, Yildirir A, Akcay A, Colak T, Ozdemir FN, Muderrisoglu H, Haberal M. Effects of immunosuppressive drugs on serum lipid levels in renal transplant recipients. Transplant Proc. 2006 Mar;38(2):502-5. 111. Selcuk H, Kanbay M, Murat K, Yilmaz U. Liver dysfunction after a gluten-free diet in a patient with celiac disease: a new link? Dig Dis Sci. 2006 Jan;51(1):213-4. 112. Kanbay M, Karakus S, Yilmaz U. Portal vein thrombosis due to hyperhomocysteinemia caused by vitamin B-12 deficiency. Dig Dis Sci. 2005 Dec;50(12):2362-3. 113. Aydogan T, Kanbay M, Uz B, Kaya A, Isik A, Bozalan R, Erkman M, Akcay A. Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. J Clin Gastroenterol. 2006 Feb;40(2):177. 114. Kanbay M, Gür G, Yücel M, Yilmaz U, Muderrisoglu H. Helicobacter pylori seroprevalence in patients with coronary artery disease. Dig Dis Sci. 2005 Nov;50(11):2071-4. 115. Guler ZM, Kanbay A, Ciftci B, Kanbay M, Yilmaz A, Agackiran Y, Erdogan Y. Kaposi sarcoma secondary to pulmonary tuberculosis: a rare case. South Med J. 2005 Sep;98(9):933-4. 116. Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc. 2005 Sep;37(7):3119-20. 15
117. Akcay A, Kanbay M, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients. Transplant Proc. 2005 Sep;37(7):3103-5. 118. Yildirim E, Kanbay M, Ozbek O, Coskun M, Boyacioglu S. Isolated idiopathic ovarian vein thrombosis: a rare case. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jul-Aug;16(4):308-10. 119. Kanbay M, Gur G, Akcay S, Yilmaz U. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med. 2005 Oct;99(10):1213-6. 120. Kanbay M, Gür G, Yücel M, Yilmaz U, Boyacioğlu S. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci. 2005 Jul;50(7):1228-31. 121. Kanbay M, Gür G, Arslan H, Yilmaz U, Boyacioglu S. The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci. 2005 Jul;50(7):1214-7. 122. Kanbay M, Sengul A, Güvener N. Trauma induced thyroid storm complicated by multiple organ failure. Chin Med J (Engl). 2005 Jun 5;118(11):963-5. 123. Kanbay M, Yildirir A, Bozbas H, Ulus T, Bilgi M, Muderrisoglu H, Akcay A, Ozdemir FN. Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. Ren Fail. 2005;27(3):297-303. 124. Kanbay M, Sekuk H, Yilmaz U, Gur G, Boyacioglu S. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. Dig Dis. 2005;23(1):92-4. 125. Kanbay M, Gür G, Boyvat F, Taşdelen A, Boyacioğlu S. Spontaneous aortocaval fistula presenting with acute liver and renal failure: a case report. Turk J Gastroenterol. 2004 Sep;15(3):169-72. 126. Kanbay M, Korkmaz M, Yilmaz U, Gur G, Boyacioglu S. Acute pancreatitis due to ramipril therapy. Postgrad Med J. 2004 Oct;80(948):617-8. 127. Kanbay M, Gür G, Korkmaz M, Demirci B, Boyacioğlu S. Hepatic lymphoma metastasis presenting with severe acute liver failure: a rare case. Turk J Gastroenterol. 2004 Jun;15(2):94-6. 128. Akcay A, Kanbay M, Agca E, Sezer S, Ozdemir FN. Neutropenia due to clopidogrel in a patient with end-stage renal disease. Ann Pharmacother. 2004 Sep;38(9):1538-9. 129. Karakuş S, Kanbay M, Köseoğlu HK, Colak T, Haberal M. Causes of anemia in renal transplant recipients. Transplant Proc. 2004 Jan-Feb;36(1):164-5. 130. Akcay A, Kanbay M, Sezer S, Ozdemir FN. Acute renal failure and hepatotoxicity associated with roxithromycin. Ann Pharmacother. 2004 Apr;38(4):721-2. 16